EAGLE PHARMACEUTICALS, INC.
EAGLE PHARMACEUTICALS, INC. (EGRX) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 339 transactions totaling $158.6M, demonstrating a bearish sentiment with -$125.2M in net insider flow. The most recent transaction on Feb 28, 2024 involved a transaction of 2,119 shares valued at $13.3K.
EGRX Insider Activity Summary
Who Is Buying EGRX Stock?
No significant insider buying has been recorded for EGRX in the recent period.
Who Is Selling EGRX Stock?
No significant insider selling has been recorded for EGRX in the recent period.
Is EAGLE PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EGRX is bearish with an Insider Alignment Score of 11/100 and a net flow of -$125.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
EGRX Frequently Asked Questions
Understanding EGRX Insider Activity
Insider trading at EAGLE PHARMACEUTICALS, INC. (EGRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading EGRX stock, having executed 339 transactions in the past 90 days. The most active insider is Associates IV Llc Proquest (Executive), who has made 38 transactions totaling $46.9M.
Related Tools
Track EAGLE PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at EGRX file new Form 4 transactions